Details for New Drug Application (NDA): 020058
✉ Email this page to a colleague
NDA 020058 describes THIOPLEX, which is a drug marketed by Immunex and is included in one NDA. Additional details are available on the THIOPLEX profile page.
The generic ingredient in THIOPLEX is thiotepa. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the thiotepa profile page.
The generic ingredient in THIOPLEX is thiotepa. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the thiotepa profile page.
Medical Subject Heading (MeSH) Categories for 020058
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 22, 1994 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
